Taila Export Market Intelligence: India's 208 Suppliers Shipping to 82 Countries — TransData Nexus 2026

Q: Who are the top taila exporters from India?

The top taila exporters from India are: 1. GREENSHIP EXPORTS — $3.8M (50.1% market share); 2. SNA OUSHADHASALA PRIVATE LIMITED — $791.9K (10.4% market share); 3. SWISS PARENTERALS LIMITED — $464.2K (6.1% market share); 4. SREE EXPORTS — $314.8K (4.1% market share); 5. KOOTHADEES TRADE PRIVATE LIMITED — $255.7K (3.4% market share). Together they account for 74.1% of India's total taila export value.

Q: What is the total export value of taila from India?

The total export value of taila from India is $7.6M USD, recorded across 6,969 shipment transactions from 208 active exporters to 82 destination countries. The average shipment value is $1.1K.

Q: Which countries import taila from India?

India exports taila to 82 countries worldwide. The top importing countries are: GERMANY (26.3% share, $2.0M), SAUDI ARABIA (19.2% share, $1.5M), UNITED ARAB EMIRATES (18.2% share, $1.4M), SLOVAK REPUBLIC (8.6% share, $651.2K), RUSSIA (3.0% share, $228.8K). These five markets account for 75.3% of total export value.

Q: What is the HS code for taila exports from India?

The primary HS code for taila exports from India is 30049011. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of taila exports from India?

The average unit price for taila exports from India is $26.54 USD per unit, with prices ranging from $0.00 to $3890.95 depending on formulation, packaging, and order volume. The total market is valued at $7.6M across 6,969 shipments.

Q: Which ports handle taila exports from India?

The primary ports for taila exports from India are COCHIN SEA (INCOK1) (19.2% of shipments), COCHIN SEA (16.9% of shipments), TUTICORIN SEA (7.6% of shipments), TUTICORIN SEA (INTUT1) (7.6% of shipments), Cochin Sea (5.0% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of taila?

India is one of the world's leading exporters of taila due to its large base of 208 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports taila to 82 countries, demonstrating 42% global market coverage.

Q: What certifications do Indian taila exporters need?

Indian taila exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import taila from India?

There are 381 registered buyers importing taila from India, spread across 82 countries. The repeat buyer rate is 73.5%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top taila supplier from India?

GREENSHIP EXPORTS is the leading taila exporter from India with a market share of 50.1% and total export value of $3.8M across 1742 shipments. The top 5 suppliers together control 74.1% of total export value.

Suresh Sormare

Taila

India Pharmaceutical Trade Intelligence

$7.6M208 Suppliers82 CountriesHS 30049011

ExportsIndia → GERMANY26.3%India → SAUDI ARABIA19.2%

#1 Supplier: GREENSHIP EXPORTS

Taila Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Taila to the World

Between 2022 and 2026, India exported $7.6M worth of taila across 6,969 verified shipments to 82 countries — covering 42% of world markets in the Ayurvedic & Herbal Products segment. The largest destination is GERMANY (26.3%). GREENSHIP EXPORTS leads with a 50.1% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049011

Taila export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Taila export data snapshot — $7.6M · 208 exporters · 82 countriesTransData Nexus · Indian Customs Data

Top Taila Exporters from India

208 active exporters · Ranked by export value

View all 208 →

Top Taila Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	GREENSHIP EXPORTS	$3.8M	1,742	8	50.1%
2	SNA OUSHADHASALA PRIVATE LIMITED

Top Countries Importing Taila from India

82 destination markets · Ranked by import value

All 82 countries →

Top Countries Importing Taila from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	GERMANY	$2.0M	26.3%
2	SAUDI ARABIA	$1.5M	19.2%
3	UNITED ARAB EMIRATES	$1.4M	18.2%
4	SLOVAK REPUBLIC	$651.2K	8.6%
5	RUSSIA	$228.8K	3.0%
6	VIETNAM	$207.9K	2.7%
7	KAZAKHSTAN	$113.6K	1.5%
8	FRANCE	$90.7K	1.2%
9	UNITED STATES	$88.8K	1.2%
10	LITHUANIA	$84.2K	1.1%

GERMANY is India's largest taila export destination, absorbing 26.3% of total exports worth $2.0M. The top 5 importing countries — GERMANY, SAUDI ARABIA, UNITED ARAB EMIRATES, SLOVAK REPUBLIC, RUSSIA — together account for 75.3% of India's total taila export value. The remaining 77 destination countries collectively receive the other 24.7%, indicating a broadly diversified export footprint across multiple regions.

Regulatory Landscape — Taila

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

As of March 2026, "Taila" (HS Code: 30049011) has not received approval from the U.S. Food and Drug Administration (FDA) under the Abbreviated New Drug Application (ANDA) pathway. A search of the FDA's Orange Book reveals no approved ANDAs for this product. Consequently, "Taila" is not authorized for marketing in the United States.

The absence of FDA approval indicates that "Taila" has not undergone the rigorous evaluation required for safety, efficacy, and quality standards in the U.S. market. This regulatory status is particularly relevant given the substantial number of Indian exporters—208 active exporters—engaged in the international distribution of "Taila." For these exporters, entering the U.S. market would necessitate navigating the FDA's comprehensive approval process, which includes submitting an ANDA demonstrating bioequivalence to a reference listed drug.

2EU & UK Regulatory Framework

In the European Union (EU) and the United Kingdom (UK), medicinal products like "Taila" require marketing authorization before they can be marketed. This authorization is granted by the European Medicines Agency (EMA) for the EU and the Medicines and Healthcare products Regulatory Agency (MHRA) for the UK. As of March 2026, there is no record of "Taila" having received such authorization from either agency.

Compliance with Good Manufacturing Practice (GMP) standards is a prerequisite for obtaining marketing authorization in these regions. Manufacturers must adhere to EU GMP guidelines, which encompass quality management, personnel qualifications, and production processes. For Indian exporters targeting the EU and UK markets, aligning with these stringent requirements is essential to ensure product quality and regulatory compliance.

3WHO Essential Medicines & Global Standards

The World Health Organization (WHO) maintains the Model List of Essential Medicines, identifying medications considered essential for basic healthcare systems. As of the latest edition, "Taila" is not included in this list. Additionally, there is no evidence of "Taila" being prequalified by the WHO, a process that assesses the quality, safety, and efficacy of medicinal products.

Regarding pharmacopoeial standards, "Taila" does not appear in the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), or Indian Pharmacopoeia (IP). Inclusion in these pharmacopoeias signifies recognized quality standards, and the absence of "Taila" suggests a lack of standardized specifications for this product.

4India Regulatory Classification

In India, the Central Drugs Standard Control Organization (CDSCO) classifies drugs into various schedules under the Drugs and Cosmetics Act. "Taila" is categorized under Schedule H, indicating that it is a prescription drug requiring a doctor's prescription for dispensation. This classification underscores the necessity for medical supervision in its use.

The National Pharmaceutical Pricing Authority (NPPA) oversees drug pricing in India. As of March 2026, "Taila" is not listed under the Drug Price Control Order (DPCO), meaning it does not have a government-mandated ceiling price. For export purposes, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) for certain pharmaceuticals. Exporters of "Taila" must ensure compliance with these regulatory requirements to facilitate international trade.

5Patent & Exclusivity Status

A review of patent databases indicates that "Taila" is not protected by any active patents as of March 2026. This lack of patent protection suggests that generic versions can be produced and marketed without infringing on intellectual property rights. However, the absence of patent barriers does not negate the need for regulatory approvals in target markets, which remain a critical factor for market entry.

6Recent Industry Developments

In July 2025, the European Medicines Agency (EMA) adopted a positive opinion recommending a new indication for Taltz, expanding its use to include juvenile idiopathic arthritis. This development reflects the EMA's ongoing efforts to address unmet medical needs in pediatric populations. (ema.europa.eu)

In January 2026, the UK's Veterinary Medicines Directorate (VMD) confirmed that no veterinary medicinal products containing mRNA platforms are authorized in the UK. This statement underscores the VMD's commitment to transparency and regulatory oversight in emerging biotechnologies. (gov.uk)

These developments highlight the dynamic nature of the pharmaceutical regulatory landscape, emphasizing the importance of staying informed about policy changes and market trends.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Supply Chain Risk Assessment — Taila

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, often referred to as the "pharmacy of the world," heavily relies on China for Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs). Approximately 70% of India's API requirements are fulfilled by Chinese manufacturers. This dependency exposes the supply chain to significant risks, as any disruption in Chinese production or export policies can lead to shortages and price volatility. For instance, during the COVID-19 pandemic, India's overreliance on Chinese APIs resulted in supply chain disruptions and price hikes, leading to shortages of various important APIs and KSMs.

To mitigate these vulnerabilities, the Indian government has initiated the Production Linked Incentive (PLI) scheme aimed at boosting domestic production of critical APIs and KSMs. In October 2024, two greenfield plants were inaugurated under this scheme to manufacture essential molecules like Penicillin G, 6-APA, and Clavulanic Acid, which are vital for common antibiotics. These efforts aim to reduce India's import dependence on key pharmaceutical ingredients by half.

2Supplier Concentration & Single-Source Risk

The export data for "Taila" from India indicates a high supplier concentration, with the top five exporters accounting for 74.1% of the total export value. Notably, GREENSHIP EXPORTS alone contributes 50.1% of the market share. Such concentration poses a significant single-source risk; any operational or financial issues faced by these key exporters could disrupt the supply chain. While the PLI scheme is a step towards enhancing domestic production capabilities, its impact on diversifying the exporter base for "Taila" remains to be seen.

Access Complete Taila Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 6,969 transactions across 82 markets.

Request Demo View Pricing

Frequently Asked Questions — Taila Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top taila exporters from India?

The leading taila exporters from India are GREENSHIP EXPORTS, SNA OUSHADHASALA PRIVATE LIMITED, SWISS PARENTERALS LIMITED, and 11 others. GREENSHIP EXPORTS leads with 50.1% market share ($3.8M). The top 5 suppliers together control 74.1% of total export value.

What is the total export value of taila from India?

The total export value of taila from India is $7.6M, recorded across 6,969 shipments from 208 active exporters to 82 countries. The average shipment value is $1.1K.

Which countries import taila from India?

India exports taila to 82 countries. The top importing countries are GERMANY (26.3%), SAUDI ARABIA (19.2%), UNITED ARAB EMIRATES (18.2%), SLOVAK REPUBLIC (8.6%), RUSSIA (3.0%), which together account for 75.3% of total export value.

What is the HS code for taila exports from India?

The primary HS code for taila exports from India is 30049011. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Taila

Taila

How India Exports Taila to the World

Top Taila Exporters from India

Top Countries Importing Taila from India

Quick Facts

Related Ayurvedic & Herbal Products

Related Analysis

Need Details?

Regulatory Landscape — Taila

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Supply Chain Risk Assessment — Taila

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Taila Trade Intelligence

Frequently Asked Questions — Taila Exports from India

Who are the top taila exporters from India?

What is the total export value of taila from India?

Which countries import taila from India?

What is the HS code for taila exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of taila exports from India?

Which ports handle taila exports from India?

Why is India a leading exporter of taila?

What certifications do Indian taila exporters need?

How many buyers import taila from India?

What is the market share of the top taila exporter from India?

Analysis Methodology